Heather McKenzie is a Senior Editor at AM850 WRUF. She covers a diverse range of topics primarily focused on medicine and healthcare, including alternative medicine, health and wellness, and competitive sports, while also delving into areas such as FDA regulations, venture capital, and the impact of startups like Pfizer during the Coronavirus pandemic. Heather's work has been featured in prominent outlets including NewsBreak, BioSpace, and ESG Investor.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Heather's coverage is predominantly focused on the healthcare and pharmaceutical industry, with a specific emphasis on FDA approvals, gene therapy, CRISPR technology, drug development, Alzheimer's disease, and CNS diseases. Her articles heavily cite data and press releases.
Given Heather’s focus on citing data and press releases in her articles about healthcare and pharmaceuticals, she may be interested in receiving pitches from experts who can provide statistical analysis or insights based on solid scientific evidence related to these topics. Pitches offering access to exclusive data or early access to research findings could also be appealing.
Heather does not appear to have a specific geographic focus but rather seems to cover global developments within the healthcare and pharmaceutical industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Heather Mckenzie, Jef Akst, Annalee Armstrong
BioSpace presents 25 noteworthy biopharma startups in ’25; analysts forecast stronger M&A as the J.P. Morgan Healthcare Conference kicks off next week; GLP-1s continue to expand their reach as Novo, Lilly fight against compounders; and a look ahead to five key FDA decisions in Q1.
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming particularly in the oncology and neurosciences spaces.
By: Heather-Mckenzie
J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma's annual kickoff conference. Meanwhile, Biogen proposes to acquire struggling neuro partner Sage, and obesity dominates discussions as Pfizer goes “all in.”
As the year gets underway, analysts and biotech executives highlight cell therapy's pivot from oncology to autoimmune diseases, a continued appetite for next-generation obesity drugs and an increased focus on neuromuscular, kidney and cardiovascular diseases.
Florida women's basketball is seeking another road win against Ole Miss Thursday evening after a dominating win against Missouri (11-8).
The Florida men's tennis team will open its spring season Monday against Georgia Southern at the Alfred A. Ring Tennis Complex at 11 a.m ET.
By: Heather Mckenzie
Former Gator Ben Shelton advances to the Australian Open quarter-finals after Gaël Monfils announced that he was retiring mid-match.
By: Heather Mckenzie
The Florida Gators Men's Tennis team defeated Georgia Southern 6-1 on Jan.20 starting off their 2025 season 1-0.
By: Heather-Mckenzie
Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM and her talks with Biogen, Gilead, Novavax and more; Wegovy's higher dose induces more weight loss; AstraZeneca and Daiichi Sankyo's Dato-DXd scores its first FDA approval.
By: Heather Mckenzie
Former Florida tennis star No. 21 Ben Shelton will face off against No.1 Jannik Sinner in the semifinals of the Australian Open.
(833) 317-6278 
